| Valuation method | Value, ¥ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 2945.50 | 21 |
| Intrinsic value (DCF) | 2275.84 | -7 |
| Graham-Dodd Method | 1948.75 | -20 |
| Graham Formula | 5021.70 | 106 |
JAFCO Group Co., Ltd. (8595.T) is a leading Japanese private equity and venture capital firm specializing in direct and fund-of-fund investments across diverse sectors, including life sciences, IT services, robotics, healthcare, and finance. Founded in 1973 and headquartered in Tokyo, JAFCO operates globally with investments in Japan, the U.S., and Europe. The firm supports businesses at all stages—from seed and early-stage startups to buyouts and business successions—leveraging its deep industry expertise to drive growth. With a market cap of ¥130.66 billion (as of latest data), JAFCO is a key player in Asia’s venture capital landscape, known for its strategic investments in high-growth industries. Its strong cash position (¥72.49 billion) and disciplined capital allocation underscore its financial stability, making it a trusted partner for entrepreneurs and institutional investors alike.
JAFCO Group presents a compelling investment case due to its diversified venture capital portfolio, strong balance sheet (¥72.49 billion in cash), and consistent profitability (¥9.58 billion net income in FY2025). The firm’s low beta (0.36) suggests resilience to market volatility, while its dividend yield (2.3% based on ¥88/share) offers income appeal. However, risks include exposure to early-stage startups (higher failure rates) and dependence on Japan’s economic climate. Its focus on high-growth sectors like life sciences and IT aligns with global trends, but competition from larger global PE firms could pressure returns. Investors should weigh its solid track record against sector-specific risks.
JAFCO Group’s competitive advantage lies in its deep regional expertise in Japan’s venture capital ecosystem, where it has cultivated long-term relationships with startups and institutional investors. Unlike global giants (e.g., Blackstone), JAFCO’s niche focus on mid-market Japanese deals allows for hands-on value creation. Its fund-of-funds strategy diversifies risk, while its ¥72.49 billion cash reserve provides dry powder for opportunistic investments. However, it lacks the scale of U.S. peers (e.g., Sequoia Capital) in cross-border deals and may face pressure from local rivals (e.g., SBI Investment) with broader fintech exposure. Strengths include a strong IRR track record in life sciences and IT, but weaknesses include limited brand recognition outside Asia and reliance on Japan’s stagnant domestic growth. Its capital-light model (low CapEx of ¥-23 million) enhances ROE, but succession risks in its leadership could pose long-term challenges.